Small interfering RNA targeting for infected-cell polypeptide 4 inhibits herpes simplex virus type 1 replication in retinal pigment epithelial cells

Clinical and Experimental Ophthalmology

Volumn 40, Issue 2, 2012, Pages 195-204

  Duan, Fang ^a   Ni, Shiming ^a   Nie, Yuhong ^a,b   Huang, Qiang ^a   Wu, Kaili ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

HSV 1; Immediate early infected cell polypeptide 4; Retinal pigment epithelium; SiRNA

Indexed keywords

ANTIVIRUS AGENT; INFECTED CELL POLYPEPTIDE 4; POLYPEPTIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORNEA EPITHELIUM; GENE SILENCING; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NONHUMAN; PIGMENT CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRABECULAR MESHWORK; VERO CELL; VIRUS CULTURE; VIRUS INHIBITION; VIRUS LOAD; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE SILENCING; GENE TARGETING; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; VERO CELLS; VIRAL PLAQUE ASSAY; VIRUS REPLICATION;

EID: 84858439631     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02668.x     Document Type: Article

References (50)

1. Everett RD. Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J 1984; 3: 3135-41.
2. Roizman B, Gu H, Mandel G. The first 30 minutes in the life of a virus: unREST in the nucleus. Cell Cycle 2005; 4: 1019-21.
3. Faber SW, Wilcox KW. Association of herpes simplex virus regulatory protein ICP4 with sequences spanning the ICP4 gene transcription initiation site. Nucleic Acids Res 1988; 16: 555-70.
4. Gallinari P, Wiebauer K, Nardi MC, Jiricny J. Localization of a 34-amino-acid segment implicated in dimerization of the herpes simplex virus type 1 ICP4 polypeptide by a dimerization trap. J Virol 1994; 68: 3809-20.
5. Su YH, Zhang X, Wang X, Fraser NW, Block TM. Evidence that the immediate-early gene product ICP4 is necessary for the genome of the herpes simplex virus type 1 ICP4 deletion mutant strain d120 to circularize in infected cells. J Virol 2006; 80: 11589-97.
6. Grondin B, DeLuca N. Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA. J Virol 2000; 74: 11504-10.
7. Livingston CM, DeLuca NA, Wilkinson DE, Weller SK. Oligomerization of ICP4 and rearrangement of heat shock proteins may be important for herpes simplex virus type 1 prereplicative site formation. J Virol 2008; 82: 6324-36.
8. Tang Q, Li L, Ishov AM, Revol V, Epstein AL, Maul GG. Determination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10. J Virol 2003; 77: 5821-8.
9. Mossman KL, Sherburne R, Lavery C, Duncan J, Smiley JR. Evidence that herpes simplex virus VP16 is required for viral egress downstream of the initial envelopment event. J Virol 2000; 74: 6287-99.
10. Weir JP. Regulation of herpes simplex virus gene expression. Gene 2001; 271: 117-30.
11. Herrera FJ, Triezenberg SJ. VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. J Virol 2004; 78: 9689-96.
12. Kashiwase M, Sata T, Yamauchi Y etal. Progressive outer retinal necrosis caused by herpes simplex virus type 1 in a patient with acquired immunodeficiency syndrome. Ophthalmology 2000; 107: 790-4.
13. Tiwari V, Oh MJ, Kovacs M, Shukla SY, Valyi-Nagy T, Shukla D. Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells. FEBS J 2008; 275: 5272-85.
14. Nie Y, Deng J, Liu S, Huang Q, Wu K. [Effects of HSV-1 on the growth of human retinal pigment epithelial cells]. Yan Ke Xue Bao 2007; 23: 212-18.
15. Fraefel C, Mendes-Madeira A, Mabon O etal. In vivo gene transfer to the rat retina using herpes simplex virus type 1 (HSV-1)-based amplicon vectors. Gene Ther 2005; 12: 1283-8.
16. Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis features, management, and outcomes. Ophthalmology 2007; 114: 756-62.
17. Kim C, Yoon YH. Unilateral acute retinal necrosis occurring 2years after herpes simplex type 1 encephalitis. Ophthalmic Surg Lasers 2002; 33: 250-2.
18. Ganatra JB, Chandler D, Santos C, Kuppermann B, Margolis TP. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol 2000; 129: 166-72.
19. Duker JS, Nielsen JC, Eagle RC, Jr, Bosley TM, Granadier R, Benson WE. Rapidly progressive acute retinal necrosis secondary to herpes simplex virus, type 1. Ophthalmology 1990; 97: 1638-43.
20. Klein A, Lefebvre P. Three consecutive episodes of acute retinal necrosis due to herpes simplex-1 over twelve years following herpetic encephalitis. Ocul Immunol Inflamm 2007; 15: 411-13.
21. Toma HS, Murina AT, Areaux RG etal. Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol 2008; 23: 249-73.
22. Aigner A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol 2006; 124: 12-25.
23. Andino R. RNAi puts a lid on virus replication. Nat Biotechnol 2003; 21: 629-30.
24. Haasnoot PC, Cupac D, Berkhout B. Inhibition of virus replication by RNA interference. J Biomed Sci 2003; 10: 607-16.
25. Zhe R, Mei-Ying Z, Kitazato K etal. Effect of siRNA on HSV-1 plaque formation and relative expression levels of UL39 mRNA. Arch Virol 2008; 153: 1401-6.
26. Zhang YQ, Lai W, Li H, Li G. Inhibition of herpes simplex virus type 1 by small interfering RNA. Clin Exp Dermatol 2008; 33: 56-61.
27. Bhuyan PK, Kariko K, Capodici J etal. Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes. J Virol 2004; 78: 10276-81.
28. Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008; 454: 780-3.
29. Shen W, Sa e Silva M, Jaber T etal. Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis. J Virol 2009; 83: 9131-9.
30. Liu J, Song G, Wang Z etal. Establishment of a corneal epithelial cell line spontaneously derived from human limbal cells. Exp Eye Res 2007; 84: 599-609.
31. Yu M, Sun J, Peng W etal. Protein expression in human trabecular meshwork: downregulation of RhoGDI by dexamethasone in vitro. Mol Vis 2010; 16: 213-23.
32. Nie Y, Cui D, Pan Z, Deng J, Huang Q, Wu K. HSV-1 infection suppresses TGF-beta1 and SMAD3 expression in human corneal epithelial cells. Mol Vis 2008; 14: 1631-8.
33. Ma X, Wu MX, Zhang YL, Cui DM, Li MT, Wu KL. Difference of gene expression between the central and the peripheral epithelia of the bovine lens. Chin Med J (Engl) 2009; 122: 1072-80.
34. Triezenberg SJ, LaMarco KL, McKnight SL. Evidence of DNA: protein interactions that mediate HSV-1 immediate early gene activation by VP16. Genes Dev 1988; 2: 730-42.
35. Calle A, Ugrinova I, Epstein AL, Bouvet P, Diaz JJ, Greco A. Nucleolin is required for an efficient herpes simplex virus type 1 infection. J Virol 2008; 82: 4762-73.
36. Bedadala GR, Pinnoji RC, Hsia SC. Early growth response gene 1 (Egr-1) regulates HSV-1 ICP4 and ICP22 gene expression. Cell Res 2007; 17: 546-55.
37. Stram Y, Kuzntzova L. Inhibition of viruses by RNA interference. Virus Genes 2006; 32: 299-306.
38. Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002; 418: 430-4.
39. Morris KV, Chung CH, Witke W, Looney DJ. Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol. RNA Biol 2005; 2: 17-20.
40. Ren GL, Bai XF, Zhang Y etal. Stable inhibition of hepatitis B virus expression and replication by expressed siRNA. Biochem Biophys Res Commun 2005; 335: 1051-9.
41. Randall G. Grakoui A and Rice CM. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci U S A 2003; 100: 235-40.
42. Muylaert I, Elias P. Knockdown of DNA ligase IV/XRCC4 by RNA interference inhibits herpes simplex virus type I DNA replication. J Biol Chem 2007; 282: 10865-72.
43. Liu YP, von Eije KJ, Schopman NC etal. Combinatorial RNAi against HIV-1 using extended short hairpin RNAs. Mol Ther 2009; 17: 1712-23.
44. Shi Y, Yang DH, Xiong J, Jia J, Huang B, Jin YX. Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. Cell Res 2005; 15: 193-200.
45. Shin D, Lee H, Kim SI, Yoon Y, Kim M. Optimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virus. RNA 2009; 15: 898-910.
46. Liu YT, Song B, Wang YL etal. [SiRNA targeting ICP4 attenuates HSV-1 replication]. Bing Du Xue Bao 2010; 26: 163-9.
47. Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference-based therapeutics. Nature 2009; 457: 426-33.
48. Kim SH, Mok H, Jeong JH, Kim SW, Park TG. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug Chem 2006; 17: 241-4.
49. Kaiser PK, Symons RC, Shah SM etal. RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol 2010; 150: 33-9.
50. Simonelli F, Maguire AM, Testa F etal. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5years after vector administration. Mol Ther 2010; 18: 643-50.